Monday Morning's Movers: LGF, MSFT, SRE >>> READ MORE

IBB

3 Biotech Trades for the Faux Doomsday Scenario

Biotech stocks have been a political football throughout the campaign and even now. Sell risk against the fear and the hope for a profit. More 

IShares Nasdaq Biotechnology Index (ETF) (IBB): Short the Near-Term Action in the IBB ETF

Drug stocks have been hated by traders for more than a year, but that feeling is abating. Use long-term value to short IBB over the near term. More 

Biogen Inc (BIIB): Profit From the BIIB Stock Bears

Love it or hate it, the severe chop in Big Pharma presents opportunities to create income. Sell risk against value levels in Biogen (BIIB) stock. More 

Is Now the Time to Buy Into These 5 Biotech ETFs?

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out More 

Illumina, Inc. (ILMN) Stock Is Nearing Breakout Territory

Illumina (ILMN) looks ripe for a break higher after ILMN stock spent the majority of the past two months in a sideways range. More 

Buy Bristol-Myers Squibb Co (BMY) Stock Without Fear

The consensus is that Trump will destroy the Biotech industry. I bet this will pass with little change, so go long BMY with room for error. More 

iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Crossroads

The iShares Nasdaq Biotechnology ETF (IBB) is showing relative strength, but the IBB ETF must overcome this hurdle to continue rallying. More